美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

First Trust Indxx Medical Devices ETF

20.30

+0.27901.39%

盤後：20.18-0.1169-0.58%16:10 EDT

成交量：265

成交額：5,377

市值：304.46萬

市盈率：- -

高：20.30

開：20.18

低：20.18

收：20.02

52周最高：21.82

52周最低：17.85

股本：15.00萬

流通股本：15.00萬

量比：0.23

換手率：0.18%

股息：0.02

股息率：0.11%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證

新華醫療：獲得三類及二類醫療器械註冊證

國金證券：雙輪驅動醫療器械內外復甦聚焦創新與出海主線

港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍戰略重心轉向高附加值醫療器械賽道

透景生命(300642.SZ)取得醫療器械註冊證

醫療器械迎業績拐點？512170成功收紅！AI4S帶火港股CXO，金斯瑞升逾7%！港股通醫療ETF華寶逆市上揚

賽諾醫療：子公司輸送型球囊擴張導管獲醫療器械註冊證

東方海洋(002086.SZ)：清道夫受體-A(SR-A)測定試劑盒獲得醫療器械註冊證

美年健康在寧波投資成立數智科技公司

步步高等成立商貿公司

透景生命(300642.SZ)子公司取得醫療器械註冊證

凱普生物(300639.SZ)子公司取得醫療器械註冊證書

今天北交所新股百邁科申購，聚焦外科手術醫療器械領域

國家藥監局召開醫療器械臨床研究成果轉化暨「春雨行動」工作推進會

達芬奇全新手術機器人獲批，殺入奧林巴斯腹地

真健康醫療(02697.HK)首份中期業績出爐：收入按年增長逾30倍穿刺手術機器人商業化提速

真健康醫療(02697)首份中期業績出爐：收入按年增長逾30倍穿刺手術機器人商業化提速

石藥集團在石家莊成立健康創新科技公司

美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款9330萬美元，用於在佐治亞州擴展遠程醫療服務、推進手術機器人技術及改

錦波生物中報遇冷：重組膠原蛋白龍頭高增長敍事遇考驗

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/MDEV/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MDEV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDEV\",,,,,undefined,":{"symbol":"MDEV","market":"US","secType":"STK","nameCN":"First Trust Indxx Medical Devices ETF","latestPrice":20.2969,"timestamp":1789416000000,"preClose":20.0179,"halted":0,"volume":265,"hourTrading":{"tag":"盘后","latestPrice":20.18,"preClose":20.2969,"latestTime":"16:10 EDT","volume":6,"amount":121.7814,"timestamp":1789416603917,"change":-0.1169,"changeRate":-0.00576,"amplitude":0},"delay":0,"changeRate":0.01393752591430669,"floatShares":150002,"shares":150002,"eps":0,"marketStatus":"已收盤","change":0.279,"latestTime":"09-14 16:00:00 EDT","open":20.18,"high":20.2969,"low":20.18,"amount":5377,"amplitude":0.00584,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":20.0179,"sharesOutstanding":100002,"nav":20.21,"aum":3031540.42,"dividendRate":0.001104,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":20.18,"preClose":20.2969,"latestTime":"16:10 EDT","volume":6,"amount":121.7814,"timestamp":1789416603917,"change":-0.1169,"changeRate":-0.00576,"amplitude":0},"volumeRatio":0.226341,"impliedVol":0.3604,"impliedVolPercentile":0.6335},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDEV\",,,,,undefined,":{"symbol":"MDEV","floatShares":150002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.226341,"shares":150002,"dividePrice":0.0224,"high":20.2969,"amplitude":0.00584,"preClose":20.0179,"low":20.18,"week52Low":17.8532,"pbRate":"--","week52High":21.82,"institutionHeld":0,"latestPrice":20.2969,"eps":0,"divideRate":0.001104,"volume":265,"delay":0,"ttmEps":0,"open":20.18,"prevYearClose":21.117,"prevWeekClose":20.0179,"prevMonthClose":21.2998,"prevQuarterClose":19.1533,"fiveDayClose":20.9589,"twentyDayClose":21.4488,"sixtyDayClose":18.7695},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDEV\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"MDEV","amount":0.0217,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Indxx Medical Devices ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDEV\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-25","recordDate":"2026-06-25","paymentDate":"2026-06-30","value":0.0217,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDEV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDEV\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664489420","title":"新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489420","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489420?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗 发布公告，公司近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》、子公司新华手术器械有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》。该产品取得注册证后，不仅丰富了公司在微创腔镜领域的产品矩阵，也提升了在胸腔镜手术领域的综合竞争力，有助于扩大市场覆盖范围并增强品牌影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","MEDX","PTH","BK0251","GDOC","600587","09996","LNGR","HART","IEIH","LGHT","BK1583","BK0028","RSPH","BK1574","159883","AGNG","BK1100","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489426","title":"新華醫療：獲得三類及二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489426?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","MDEV","HART","MEDX","AGNG","LGHT","LNGR","PTH","IEIH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894673","title":"國金證券：雙輪驅動醫療器械內外復甦 聚焦創新與出海主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894673?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:25","pubTimestamp":1788333958,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国金证券发布研报称，医疗器械板块当前投资应紧扣“出海拓增量、创新守利润”的双轮驱动逻辑，同时把握国内需求复苏节奏。出海能有效分散集采风险，打开成长天花板，而持续的高强度研发投入则是维持高毛利率、抵御价格战的关键护城河。国金证券主要观点如下：医疗设备收入端同比稳定增长，毛利率略有承压。医疗耗材收入增速快速恢复，毛利率显著提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","09996","GDOC","BK0183","159883","AGNG","BK1583","PTH","BK0276","BK1100","LNGR","BK0201","BK0188","IEIH","RSPH","BK0028","BK0012","600109","LGHT","HART","MEDX","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899822","title":"港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍 戰略重心轉向高附加值醫療器械賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899822","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899822?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 14:04","pubTimestamp":1788329049,"startTime":"0","endTime":"0","summary":"消息面上，近期，今海医疗科技披露2026年中期业绩。2026年上半年，集团实现收益3402.1万新加坡元，同比大幅增长134.16%，展现出强劲的销售增长动能。业务端，2026年上半年，公司收入结构显著优化，战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。继2025年医疗器械销售收益实现良好增长后，2026年上半年该业务收益同比激增301.5%，达到2542.7万新加坡元，可持续增长动力充足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1100","02225","LNGR","RSPH","MEDX","LGHT","BK1574","159883","PTH","09996","BK4585","AGNG","IEIH","BK1583","GDOC","VXUS","BK1150","BK4588","HART","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855470","title":"透景生命(300642.SZ)取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855470","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855470?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:34","pubTimestamp":1788262475,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司及控股子公司上海脉示生物技术有限公司于近日取得上海市药品监督管理局颁发的6项医疗器械注册证。上述医疗器械注册证的取得，丰富了公司及子公司在多个技术平台的产品线布局，进一步完善公司在非肿瘤检测领域的业务布局，有利于提升公司整体品牌影响力和市场拓展能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300642","MEDX","GDOC","RSPH","PTH","159883","BK1583","MDEV","IEIH","BK1574","09996","AGNG","BK0042","BK0046","BK1100","HART","LGHT","LNGR","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855519","title":"醫療器械迎業績拐點？512170成功收紅！AI4S帶火港股CXO，金斯瑞升逾7%！港股通醫療ETF華寶逆市上揚","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855519","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855519?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:12","pubTimestamp":1788261120,"startTime":"0","endTime":"0","summary":"9月1日，A股港股医疗板块逆市表现，医疗ETF华宝、港股通医疗ETF华宝等相关品种热度再升温。医疗器械方面，英科医疗上半年营收、净利双增，迈瑞医疗利润降幅显著收窄至5.4%，联影医疗营收同比增长17%。中信建投研报指出，医疗器械行业迎来业绩修复拐点，2026Q2归母净利润实现四年首正增长，板块整体企稳回升。聚焦医疗器械+医疗服务，CXO含量超30%，兼顾脑机接口、AI医疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-01/doc-iniqipis4811448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PTH","LGHT","MEDX","BK4585","09996","WX","AGNG","CXO","IEIH","GDOC","MDEV","LNGR","FLHK","512170","BK1100","159883","RSPH","BK1583","KCAI","BK4588","VXUS","HART","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664858778","title":"賽諾醫療：子公司輸送型球囊擴張導管獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664858778","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664858778?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:35","pubTimestamp":1788258920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","RSPH","HART","LGHT","AGNG","IEIH","MEDX","GDOC","MDEV","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831017","title":"東方海洋(002086.SZ)：清道夫受體-A(SR-A)測定試劑盒獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831017?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 16:03","pubTimestamp":1788249802,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司全资子公司艾维可生物科技有限公司自主研发的清道夫受体-A(SR-A)测定试剂盒(磁微粒化学发光法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。该产品用于体外定性测定人体血清、血浆中的清道夫受体-A(SR-A)。上述产品获准上市，进一步丰富了艾维可生物科技有限公司在临床检测领域的产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RSPH","BK0092","BK1583","MDEV","09996","IEIH","MEDX","BK1100","BK0213","BK0046","PTH","HART","159883","AGNG","GDOC","BK1574","002086","LGHT","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831126","title":"美年健康在寧波投資成立數智科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831126?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","IEIH","MEDX","LNGR","PTH","MDEV","LGHT","RSPH","GDOC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880657","title":"步步高等成立商貿公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880657","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 11:46","pubTimestamp":1788234379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","MDEV","LNGR","LGHT","MEDX","AGNG","IEIH","HART","PTH","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663074020","title":"透景生命(300642.SZ)子公司取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074020?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:34","pubTimestamp":1788172480,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司控股子公司河北透景生命科技有限公司于近日取得国家药品监督管理局颁发的1项医疗器械注册证，产品为曲霉半乳甘露聚糖检测试剂盒(磁微粒化学发光法)。该产品可用于体外定性检测人血清或肺泡灌洗液样本中的曲霉半乳甘露聚糖，其检测结果用于曲霉感染的辅助诊断。此次医疗器械注册证的取得，将进一步增强公司及子公司在真菌检测领域的综合竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LGHT","MEDX","HART","AGNG","BK1574","MDEV","RSPH","BK0239","BK0046","PTH","BK0042","300642","LNGR","09996","BK1100","BK1583","GDOC","IEIH","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075807","title":"凱普生物(300639.SZ)子公司取得醫療器械註冊證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075807","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075807?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 16:36","pubTimestamp":1788165374,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布公告，近日，公司的全资子公司潮州凯普生物化学有限公司(简称“凯普化学”)取得国家药品监督管理局颁发的《中华人民共和国医疗器械注册证(体外诊断试剂)》，产品名称：基孔肯雅病毒/登革病毒核酸检测试剂盒(荧光PCR法)，该产品用于体外定性检测人血清或血浆样本中的基孔肯雅病毒和登革病毒的核酸。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MDEV","BK0042","AGNG","BK1583","300639","BK1100","BK0132","RSPH","BK0046","159883","MEDX","PTH","GDOC","LNGR","LGHT","HART","IEIH","BK0239","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663208770","title":"今天北交所新股百邁科申購，聚焦外科手術醫療器械領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2663208770","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663208770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 14:57","pubTimestamp":1788159461,"startTime":"0","endTime":"0","summary":"顶格申购所需资金约811万元","market":"sg","thumbnail":"https://img3.gelonghui.com/6cf81-9c6111b2-4705-4ed4-93b5-2372ef807bf8.jpg?guru_height=852&guru_width=1280&guru_size=179202","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/6cf81-9c6111b2-4705-4ed4-93b5-2372ef807bf8.jpg?guru_height=852&guru_width=1280&guru_size=179202"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6430275","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IEIH","MDEV","BK1100","MEDX","159883","GDOC","LNGR","BK1574","PTH","RSPH","AGNG","LGHT","09996","BK1583","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663002935","title":"國家藥監局召開醫療器械臨床研究成果轉化暨「春雨行動」工作推進會","url":"https://stock-news.laohu8.com/highlight/detail?id=2663002935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663002935?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:38","pubTimestamp":1788143908,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","GDOC","LGHT","IEIH","HART","LNGR","MEDX","AGNG","RSPH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663026764","title":"達芬奇全新手術機器人獲批，殺入奧林巴斯腹地","url":"https://stock-news.laohu8.com/highlight/detail?id=2663026764","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663026764?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:20","pubTimestamp":1788142836,"startTime":"0","endTime":"0","summary":"过去二十年，直观外科将达芬奇机器人辅助腹腔镜手术从实验室推向了全球手术室。胃肠道柔性手术机器人并非一个完全空白市场，相反，这一市场已经被多家企业看好。全球胃肠道内窥镜霸主奥林巴斯多线布局这一市场，国内已有企业卖出数十台消化内镜手术机器人。全球消化内镜领域的头部企业正加速推进手术机器人的商业化落地，行业整体已从概念验证阶段迈入快速发展期。国际市场上，进展较快的消化内镜手术机器人来自EndoQuest。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8w27hU00Q46","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["HTEC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662999740","title":"真健康醫療(02697.HK)首份中期業績出爐：收入按年增長逾30倍 穿刺手術機器人商業化提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2662999740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662999740?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:14","pubTimestamp":1787926492,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HTEC","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662977099","title":"真健康醫療(02697)首份中期業績出爐：收入按年增長逾30倍 穿刺手術機器人商業化提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2662977099","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662977099?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:14","pubTimestamp":1787926492,"startTime":"0","endTime":"0","summary":"智通财经APP讯，8月28日，真健康医疗 交出上市后首份中期成绩单，商业化落地迈出关键一步。收入结构显示，手术机器人销售收入516.0万元，占比达91.0%;耗材销售收入40.8万元，同比增长135.8%。公司核心产品经皮穿刺手术机器人共四个型号，均已获得国家药监局三类注册证，其中TH-S被认定为“国内首创”，关键产品TH-X MW被认定为“国际首创”。报告期内，真健康医疗研发开支2693.1万元，同比增长15.2%，公司研发团队72人，占员工总数约45.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02697","MDEV","BK1100","159891","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662059157","title":"石藥集團在石家莊成立健康創新科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662059157","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662059157?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 13:58","pubTimestamp":1787896694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","IEIH","MEDX","LNGR","PTH","MDEV","LGHT","RSPH","GDOC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662702216","title":"美國醫療保險和醫療補助服務中心：特朗普政府宣佈撥款9330萬美元，用於在佐治亞州擴展遠程醫療服務、推進手術機器人技術及改","url":"https://stock-news.laohu8.com/highlight/detail?id=2662702216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662702216?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 20:14","pubTimestamp":1787832855,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["UNHG","BK4585","SG9999014013.SGD","BMED","LU1093756325.SGD","IHF","RSPH","LU0390134368.USD","FDHT","LU0348723411.USD","UNHU","LU0170899867.USD","LU0208291251.USD","LU0211331839.USD","UN","LU0417517546.SGD","HTEC","LGHT","UNHW","BK4588","IEHS","HEAL","LU0256863811.USD","BK4154","LU0320765489.SGD","HUM","EKG","SG9999014021.USD","SG9999014005.SGD","MDEV","IEIH","LU1093756168.USD","GDOC","LU0266013472.USD","LU1983260115.SGD","LU0070302665.USD","BK4533","LU0238689110.USD","BK4566","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662677438","title":"錦波生物中報遇冷：重組膠原蛋白龍頭高增長敍事遇考驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2662677438","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662677438?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 16:36","pubTimestamp":1787819760,"startTime":"0","endTime":"0","summary":"近日，重组胶原蛋白头部企业锦波生物发布2026年半年报。02高毛利光环之下，行业周期与研发投入暗藏长期风险锦波生物依旧拥有行业内较高毛利率，但是高毛利已经难以维持高增长，赛道内卷正在逐步侵蚀原有优势。同行对比来看，巨子生物占据营收龙头位置，创尔生物处于规模爬坡阶段，行业竞争进一步加剧，锦波生物高毛利优势正被增长乏力抵消。对于锦波生物而言，护肤品业务的增长，暂时无法弥补医疗器械主业的下滑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-08-27/doc-iniptxkt9108819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1574","HART","BK1100","PTH","MDEV","IEIH","LGHT","GDOC","RSPH","AGNG","LNGR","09996","MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}